{
  "author": {
    "name": "Eric J Weiner",
    "webUrl": "/author/profile/eric-j-weiner/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2018/08/14/icahn-drops-opposition-to-cigna-express-scripts-de/",
        "title": "Icahn drops opposition to Cigna-Express Scripts deal",
        "byline": "Eric J Weiner",
        "kicker": "Market Insights",
        "prettyDate": "August 14, 2018",
        "timeToRead": "4 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/03/0615cigna_ap-e1520521890865.jpg",
          "width": "650",
          "height": "433"
        },
        "authors": [
          {
            "webUrl": "/author/profile/eric-j-weiner/",
            "name": "Eric J Weiner"
          }
        ],
        "kickerNode": [
          {
            "uri": "/market-insights/",
            "sectionName": "Market Insights"
          }
        ],
        "summary": "Shareholder Carl Icahn had previously opposed the deal, saying it would be a “travesty” if it were to proceed.",
        "body": null
      }
    ]
  }
}